Emergent BioSolutions (EBS) Posts Wide Q3 Miss; Reaffirms Guidance
Emergent BioSolutions (NYSE: EBS) reports Q3 EPS of ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
